Viewing Study NCT01622660

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-05-31 @ 12:35 PM
Study NCT ID: NCT01622660
Status: TERMINATED
Last Update Posted: 2017-08-22
First Post: 2012-06-15
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bladder Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None URETER View
None URINARY BLADDER View
None renal pelvis View
None GEMCITABINE View
None GW786034 (PAZOPANIB) View
None 11-191 View